Yongli Li

机构：Kunming University of Science and Technology, Harbin Medical University, First People's Hospital of Yunnan Province, The First Hospital of Kunming, Jilin University of Chemical Technology, Second Affiliated Hospital of Harbin Medical University, Yunnan University of Traditional Chinese Medicine · ORCID：0000-0001-7293-5313

发表论文 49 篇 · 总被引 951 次 · h-index 18

代表论文

• Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China (2021 · Stroke · 被引 135)
• Berberine Protects Against Simulated Ischemia/Reperfusion Injury-Induced H9C2 Cardiomyocytes Apoptosis In Vitro and Myocardial Ischemia/Reperfusion-Induced Apoptosis In Vivo by Regulating the Mitophagy-Mediated HIF-1α/BNIP3 Pathway (2020 · Frontiers in Pharmacology · 被引 100)
• Ferritinophagy‐Mediated Ferroptosis and Activation of Keap1/Nrf2/HO‐1 Pathway Were Conducive to EMT Inhibition of Gastric Cancer Cells in Action of 2,2  ′ ‐Di‐pyridineketone Hydrazone Dithiocarbamate Butyric Acid Ester (2022 · Oxidative Medicine and Cellular Longevity · 被引 72)
• Thrombectomy Versus Combined Thrombolysis and Thrombectomy in Patients With Acute Stroke (2021 · Stroke · 被引 68)
• The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1α pathway (2021 · Journal of Inorganic Biochemistry · 被引 41)
• The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway (2020 · Chemico-Biological Interactions · 被引 39)